Nishimura, T., Tada, H., Nakagawa, M., Teramukai, S., Matsui, S., & Fukushima, M. (2006). Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures. Centro de Investigaciones y Publicaciones Farmaceuticas.

Nishimura, Tsutomu, Harue Tada, Masatsugu Nakagawa, Satoshi Teramukai, Shigeyuki Matsui, a Masanori Fukushima. Lessons From Gefitinib-induced Interstitial Lung Disease in Japan: Problems in Approval, Pharmacovigilance, and Regulatory Decision-making Procedures. Centro de Investigaciones y Publicaciones Farmaceuticas, 2006.

Nishimura, Tsutomu, et al. Lessons From Gefitinib-induced Interstitial Lung Disease in Japan: Problems in Approval, Pharmacovigilance, and Regulatory Decision-making Procedures. Centro de Investigaciones y Publicaciones Farmaceuticas, 2006.